Considering that literature data shows the involvement of other genes of the family, including PRDM15 in lymphoproliferative diseases [60], the preliminary evidence of our study allows us to hypothesize the use of drugs directed against RIZ or BLIMP1 to prevent or modify the response of cells to activation and cell differentiation and as a useful tool also for cancer therapy. Here, PRDM15 is linked to cancer.